Insulin Aspart Injection Shortage
Last Updated: July 21, 2025
Status: Discontinued
To Be Discontinued:
- Insulin Aspart, Injection, 10 mL Insulin Aspart vial (Novo Nordisk, Inc.)
- Insulin Aspart, Injection, 3 mL Insulin Aspart FlexPen® (Novo Nordisk, Inc.)
- Insulin Aspart, Injection, 3 mL Insulin Aspart PenFill® cartridge (Novo Nordisk, Inc.)
Insulin Aspart, Injection, 10 mL Insulin Aspart vial (Novo Nordisk, Inc.)
NDC Code: 73070-100-11Status: To Be Discontinued
Date of update: July 21, 2025
Update type: New
Related Information: Unbranded Insulin Aspart 10 mL vial will continue to be shipped to wholesalers while supplies last, up until the discontinuation dates. Full discontinuation will occur on December 31, 2025.
Therapeutic category: Endocrinology/Metabolism
Date discontinued: July 21, 2025
Initial posting date: July 21, 2025
Contact info: 609-987-5800
Insulin Aspart, Injection, 3 mL Insulin Aspart FlexPen® (Novo Nordisk, Inc.)
NDC Code: 73070-103-15Status: To Be Discontinued
Date of update: July 21, 2025
Update type: New
Related Information: Unbranded Insulin Aspart 3 mL FlexPen® will continue to be shipped to wholesalers while supplies last, up until the discontinuation dates. Full discontinuation will occur on December 31, 2025.
Therapeutic category: Endocrinology/Metabolism
Date discontinued: July 21, 2025
Initial posting date: July 21, 2025
Contact info: 609-987-5800
Insulin Aspart, Injection, 3 mL Insulin Aspart PenFill® cartridge (Novo Nordisk, Inc.)
NDC Code: 73070-102-15Status: To Be Discontinued
Date of update: July 21, 2025
Update type: New
Related Information: Unbranded Insulin Aspart 3 mL PenFill® cartridge will continue to be shipped to wholesalers while supplies last, up until the discontinuation dates. Full discontinuation will occur on December 31, 2025.
Therapeutic category: Endocrinology/Metabolism
Date discontinued: July 21, 2025
Initial posting date: July 21, 2025
Contact info: 609-987-5800
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.